… duration on the rate of remission and response to biologic therapy. We specifically … efficacy
of biologics in patients with early (short-duration) disease vs those with long-duration disease. …

… and management strategies of inflammatory bowel disease. … efficacy of FDA-approved
biologics’ in patients with early short-term disease versus those with a long-duration of disease. …

… The primary outcome was the proportional biologic/placebo … short-duration (≤18months)
versus long-duration disease (>18months) analyzed separately for CD and ulcerative colitis (…

… Patients with inflammatory bowel disease (IBD) who receive … use and efficacy of biological
therapy in a tertiary IBD center. … versus long-duration inflammatory bowel disease: a …

… specifically investigated the efficacy of long vs. short duration of combination therapy in IBD.
… Firstly, patients who had received long duration combination therapy may have been the …

… The RA studies reported similar findings on factors associated with likely relapse off medications.
Patients with a long duration of disease prior to starting treatment, and a short duration …

… in a sequence of biologic therapies for CD affects clinical effectiveness outcomes of quality‐…
treated with biologic therapy early in the disease course.Choosing the correct initial biologic …

… Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease:
A systematic review and an individual-patient data meta-analysis of randomized controlled …

… Efficacy of biologic drugs in short-duration versus long-duration inflammatory bowel disease:
a systematic review and an individual-patient data meta-analysis of randomized controlled …

… have proven the efficacy of oral vancomycin therapy in CDI, … a priori—long-duration vancomycin
(LD) and short-duration … (non-CDI antibiotics), or biologic therapy, which were previously …